Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Mayer

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Oncogene|February 16, 1999
Mechanism of activation of Pak1 kinase by membrane localizationW Lu, B J Mayer
Trends in Cell Biology|January 1, 1993
Signalling through SH2 and SH3 domainsB J Mayer, D Baltimore
Journal of Virology|August 1, 1990
Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformationB J Mayer, H Hanafusa
Current Biology : CB|April 1, 1995
SH3 domains. Minding your p's and q'sB J Mayer, M J Eck
Oncogene|November 12, 1998
Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in XenopusR W Gupta, B J Mayer
Chemistry & Biology|October 6, 1999
Engineering temperature-sensitive SH3 domainsM C Parrini, B J Mayer
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1988
Characterization of p47gag-crk, a novel oncogene product with sequence similarity to a putative modulatory domain of protein-tyrosine kinases and phospholipase CB J Mayer, M Hamaguchi, H Hanafusa
Current Biology : CB|March 1, 1995
Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinasesB J Mayer, H Hirai, R Sakai
FEBS Letters|July 22, 1996
Growth inhibition by Abl requires an interplay of its SH2 and tyrosine kinase domainsT Mattioni, B J Mayer, D Picard
Molecular and Cellular Biology|December 1, 1995
Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteinsM Tanaka, R Gupta, B J Mayer
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Oncogene|February 16, 1999
Mechanism of activation of Pak1 kinase by membrane localizationW Lu, B J Mayer
Trends in Cell Biology|January 1, 1993
Signalling through SH2 and SH3 domainsB J Mayer, D Baltimore
Journal of Virology|August 1, 1990
Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformationB J Mayer, H Hanafusa
Current Biology : CB|April 1, 1995
SH3 domains. Minding your p's and q'sB J Mayer, M J Eck
Oncogene|November 12, 1998
Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in XenopusR W Gupta, B J Mayer
Chemistry & Biology|October 6, 1999
Engineering temperature-sensitive SH3 domainsM C Parrini, B J Mayer
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1988
Characterization of p47gag-crk, a novel oncogene product with sequence similarity to a putative modulatory domain of protein-tyrosine kinases and phospholipase CB J Mayer, M Hamaguchi, H Hanafusa
Current Biology : CB|March 1, 1995
Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinasesB J Mayer, H Hirai, R Sakai
FEBS Letters|July 22, 1996
Growth inhibition by Abl requires an interplay of its SH2 and tyrosine kinase domainsT Mattioni, B J Mayer, D Picard
Molecular and Cellular Biology|December 1, 1995
Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteinsM Tanaka, R Gupta, B J Mayer
Pageof 7